A1BXB
Pritelivir
| Created: | 2025-02-19 |
| Last modified: | 2025-08-13 |
Find Related PDB Entry |
|---|
Find related ligands: |
|---|
Chemical Details | |
|---|---|
| Formal Charge | 0 |
| Atom Count | 45 |
| Chiral Atom Count | 0 |
| Bond Count | 47 |
| Aromatic Bond Count | 17 |
Chemical Component Summary | |
|---|---|
| Name | Pritelivir |
| Synonyms | N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-2-[4-(pyridin-2-yl)phenyl]acetamide |
| Systematic Name (OpenEye OEToolkits) | ~{N}-methyl-~{N}-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-2-(4-pyridin-2-ylphenyl)ethanamide |
| Formula | C18 H18 N4 O3 S2 |
| Molecular Weight | 402.491 |
| Type | NON-POLYMER |
Chemical Descriptors | |||
|---|---|---|---|
| Type | Program | Version | Descriptor |
| SMILES | ACDLabs | 14.52 | Cc1nc(sc1S(N)(=O)=O)N(C)C(=O)Cc1ccc(cc1)c1ccccn1 |
| SMILES | CACTVS | 3.385 | CN(C(=O)Cc1ccc(cc1)c2ccccn2)c3sc(c(C)n3)[S](N)(=O)=O |
| SMILES | OpenEye OEToolkits | 3.1.0.0 | Cc1c(sc(n1)N(C)C(=O)Cc2ccc(cc2)c3ccccn3)S(=O)(=O)N |
| Canonical SMILES | CACTVS | 3.385 | CN(C(=O)Cc1ccc(cc1)c2ccccn2)c3sc(c(C)n3)[S](N)(=O)=O |
| Canonical SMILES | OpenEye OEToolkits | 3.1.0.0 | Cc1c(sc(n1)N(C)C(=O)Cc2ccc(cc2)c3ccccn3)S(=O)(=O)N |
| InChI | InChI | 1.06 | InChI=1S/C18H18N4O3S2/c1-12-17(27(19,24)25)26-18(21-12)22(2)16(23)11-13-6-8-14(9-7-13)15-5-3-4-10-20-15/h3-10H,11H2,1-2H3,(H2,19,24,25) |
| InChIKey | InChI | 1.06 | IVZKZONQVYTCKC-UHFFFAOYSA-N |
Drug Info: DrugBank
DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
| DrugBank ID | DB11844 |
|---|---|
| Name | Pritelivir |
| Groups | investigational |
| Description | Pritelivir has been used in trials studying the prevention of HSV-2 and Genital Herpes. |
| Synonyms | Pritelivir |
| Categories |
|
| CAS number | 348086-71-5 |
Related Resource References
| Resource Name | Reference |
|---|---|
| Pharos | CHEMBL4069597 |
| PubChem | 491941 |
| ChEMBL | CHEMBL4069597 |














